Article Versions Notes

Tsantzali I, Boufidou F, Sideri E, Mavromatos A, Papaioannou MG, Foska A, Tollos I, Paraskevas SG, Bonakis A, Voumvourakis KI, et al. From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients. Biomedicines. 2021; 9(10):1376. https://doi.org/10.3390/biomedicines9101376

Tsantzali, Ioanna, Fotini Boufidou, Eleni Sideri, Antonis Mavromatos, Myrto G. Papaioannou, Aikaterini Foska, Ioannis Tollos, Sotirios G. Paraskevas, Anastasios Bonakis, Konstantinos I. Voumvourakis, and et al. 2021. "From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients" Biomedicines 9, no. 10: 1376. https://doi.org/10.3390/biomedicines9101376

Tsantzali, I., Boufidou, F., Sideri, E., Mavromatos, A., Papaioannou, M. G., Foska, A., Tollos, I., Paraskevas, S. G., Bonakis, A., Voumvourakis, K. I., Tsivgoulis, G., Kapaki, E., & Paraskevas, G. P. (2021). From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients. Biomedicines, 9(10), 1376. https://doi.org/10.3390/biomedicines9101376